The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
gilead calistoga | 208 |
gilead sciences | 51 |
calistoga pharmaceuticals | 17 |
gilea calistoga | 2 |
gilead calistroga | 1 |
calitoga pharmaceuticals | 1 |
gilead calistoga | 23 |
gilead sciences | 2 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
therapies for hematologic malignancies | 39 | 2008 |
polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(… 🛈 | 37 | 2012 |
phosphatidylinositol 3-kinase inhibitors | 35 | 2013 |
methods for the preparation of diasteromerically pure phosphoramidate prodrugs | 33 | 2010 |
combination therapies for hematologic malignancies | 25 | 2011 |
process methods for phosphatidylinositol 3-kinase inhibitors | 23 | 2013 |
substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibito… 🛈 | 20 | 2012 |
methods of treatment for solid tumors | 19 | 2009 |
isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors | 19 | 2012 |
atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use | 19 | 2009 |